Is Invesco (IVZ) Undervalued Following Its Northern Trust Fund Range Appointment?

إنفسكو ليمتد

Invesco Ltd.

IVZ

0.00

Invesco (IVZ) has drawn fresh attention after appointing Northern Trust to support its new Irish domiciled index tracking mutual fund range. This move arrives alongside steady dividends and recently stable earnings results.

The partnership with Northern Trust comes as Invesco stock trades at $27.83, with a 90 day share price return of 22.22% and a 1 year total shareholder return of 72.28%. This suggests momentum has been building over both shorter and longer periods.

If you are comparing Invesco with other opportunities in today’s market, it can help to widen the lens and see what else is attracting attention, including 20 top founder-led companies

Invesco looks like it has the products, partnerships and dividend profile many investors want. After such a strong share price run, the real test is whether the stock still offers clear value on today’s numbers.

Most Popular Narrative: 5.1% Undervalued

Invesco's most followed valuation narrative pegs fair value at $29.32, slightly above the latest $27.83 close. This sets up a measured upside story grounded in detailed forecasts.

The company's aggressive expansion in private markets and alternative asset offerings, including strategic partnerships (e.g., with Barings and MassMutual) and increased distribution through wealth management channels, aligns with the growing demand for alternatives and could drive higher-fee revenue streams and improved earnings resilience.

Read the complete narrative. Read the complete narrative.

Want to understand why this fair value sits above the current Invesco share price? The narrative leans heavily on improving margins, a future earnings rebound, and a re rated profit multiple. The exact mix of revenue contraction, margin rebuild, and earnings scale is all mapped out in those projections.

Result: Fair Value of $29.32 (UNDERVALUED)

However, this Invesco narrative could be tested if the shift toward lower fee products continues to squeeze net revenue yield, or if higher competition and weaker flows hit margins harder than expected.

Another View: Invesco Through A Simple Sales Multiple

While the most popular Invesco narrative leans on detailed earnings forecasts and a modeled fair value, a quick reality check using the current P/S of 1.8x paints a slightly different picture. That sits a touch above a fair ratio of 1.7x, yet well below the 3.7x industry average and 6.9x peer average, which points to both valuation tension and room for debate. Is this a small premium on current sales or a discount to what the market could move towards?

For a closer look at how this sales based view stacks up against peers and the fair ratio, including where valuation risk or opportunity might sit, See what the numbers say about this price — find out in our valuation breakdown.

NYSE:IVZ P/S Ratio as at Jul 2026
NYSE:IVZ P/S Ratio as at Jul 2026

Next Steps

With Invesco attracting both optimism and caution, now is a good time to review the underlying data yourself and decide where you stand. To weigh up the key positives and concerns in one place, take a closer look at the 2 key rewards and 1 important warning sign.

Looking for more investment ideas beyond Invesco?

If you are building a watchlist around Invesco, do not stop there. Widen your search and pressure test your thinking against other stocks that fit clear, data driven criteria.

  • Target potential mispricings by scanning a focused set of 44 high quality undervalued stocks that combine solid fundamentals with prices that may not fully reflect their underlying metrics.
  • Strengthen your income stream by reviewing 8 dividend fortresses that offer higher yields while still clearing strict financial health checks.
  • Protect your capital by filtering for 73 resilient stocks with low risk scores that score well on balance sheet strength and earnings stability, so surprises are less likely to catch you off guard.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.